直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Press Release

Former Finnegan Attorneys Return to Expand IP Transactions Practice with In-House Experience

October 2, 2023

FOR IMMEDIATE RELEASE
October 2, 2023

WASHINGTON, DC—Finnegan is pleased to announce that alumni Nishla Keiser, Ph.D., and Malcolm Meeks have rejoined the firm, bringing extensive in-house insight to enhance Finnegan’s services, and expand the growing IP transactions practice. They each bring valuable experience from their various corporate and entrepreneurial roles at multinational corporations as well as startup ventures.

“We are thrilled to have Nishla and Malcolm rejoin the firm. They are both very seasoned practitioners with a wealth of in-house experience, and we look forward to working with them to continue expanding our IP transactions practice,” said Brian Kacedon, leader of Finnegan’s mechanical practice group and a recognized authority on IP transactions. He added, “Both Nishla and Malcolm spent about eight years at Finnegan, so we are always excited when alumni return; it is quite a testament to the firm’s culture.”

Nishla, who will be resident in Finnegan’s Boston office, focuses on strategic intellectual property counseling and litigation in the biotechnology, pharmaceutical, and chemical areas. She has extensive experience providing analysis for due diligence, freedom-to-operate, and patentability opinions on topics including biologic and small molecule therapeutics, gene editing and gene therapy, vaccines, drug delivery, diagnostics, and analytical methods. Prior to rejoining Finnegan, Nishla held executive roles as chief legal and strategy officer at Orna Therapeutics, Inc., and previously as senior vice president, deputy general counsel at Intellia Therapeutics, Inc. During her time at those organizations, Nishla led in-house legal preparations for multiple financings, negotiated complex collaboration and licensing deals, and advised on overall legal and IP strategy.

Malcolm, based in the firm’s Washington, DC office, focuses on complex litigation, portfolio management, and licensing in the telecommunications, semiconductor, aerospace, cybersecurity, energy, consumer goods, and automotive industries. Prior to rejoining Finnegan, Malcolm co-founded and served as the president director general of a Paris-based investment and consulting company focused on working with young (pre-seed and seed stage) French startup companies whose patentable technologies served as their business differentiator. Malcolm advised these companies both on their IP strategies to attract additional venture capital investment and on joint development agreements with larger corporations interested in their technologies. Prior to this, Malcolm served as Patent Director at France Brevets in Paris, France and Director, Corporate Patent at Infineon Technologies in Munich, Germany. Through living in Germany and France and serving as in-house patent counsel for German and French corporations, Malcolm has exceptional insights into international implications of intellectual property strategy as well as an understanding of IP’s impact on corporate risk planning, product development, and overall business strategy.

Finnegan handles IP transactions ranging from simple licenses to complex strategic alliances. The firm advises on every aspect of IP transactions, ranging from the initial confidential evaluation agreement, performing due diligence, negotiating and drafting agreements, and management of executed agreements. Our size, technical background, and experience allow us to assemble and mobilize a well-matched team that understands the technology at issue, quickly identifies key issues, and outlines a strategy for strengthening the client’s bargaining position. Our attorneys also have extensive industry experience allowing them to help clients achieve their business goals and realize their full revenue potential. As business relationships evolve, Finnegan is there to assist in enforcing or amending obligations in those agreements.

Contacts

Erika Arner, Managing Partner
erika.arner@finnegan.com

Anand K. Sharma, Chair
anand.sharma@finnegan.com


About Finnegan
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Munich, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices European, German, UK, and U.S. IP law. In addition to services related to all aspects of patent, trademark, and copyright law, including counseling, prosecution, licensing, and litigation, Finnegan provides counseling and litigation services in advertising, privacy, and a wide spectrum of additional IP-adjacent commercial matters, including trade secrets, international trade, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com and follow us on LinkedIn.

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Prosecution and Portfolio Management

Related Offices

Boston, MA

Washington, DC

Related Professionals

Malcolm T. Meeks
Partner
Washington, DC
+1 202 408 4215
Email
D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email

Related News

Commentary

Levi’s Has Filed 2 New Lawsuits This Year to Protect Its Red Tab Trademark

July 9, 2026

Commentary

‘Oyez, Oyez.’ Supreme Court’s Last Official Crier Dies at 102

July 8, 2026

Award/Ranking

Best Lawyers in Germany Recognizes Dr. Dr. Jochen Herr in Recent Rankings

July 16, 2026

Commentary

Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects

June 30, 2026

Award/Ranking

Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings

June 25, 2026

Commentary

Zync Fights Block of ITC Trade Secret Case Against BMW

June 24, 2026

Press Release

BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret

June 23, 2026

Commentary

BMW Secures Injunction Forcing Zync to Seek Stay of ITC Trade Secret Case

June 23, 2026

Award/Ranking

Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers

June 22, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP